Indivior to Participate in Upcoming Investor Events
Rhea-AI Summary
Indivior PLC (NASDAQ/LSE: INDV) has announced its participation in three major investor events in June 2025. CEO Joe Ciaffoni and CFO Ryan Preblick will attend:
1. Jefferies Global Healthcare Conference in New York City on June 4th, featuring 1x1/group meetings and a fireside discussion at 9:55 a.m. ET (publicly available via webcast)
2. Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 11th, hosting 1x1/group meetings
3. Northland Growth Conference 2025, a virtual event on June 25th, conducting 1x1/group meetings
Interested investors need to contact their respective conference representatives to schedule meetings.
Positive
- None.
Negative
- None.
News Market Reaction – INDV
In the trading session that priced this news, INDV declined 1.32%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Jefferies Global Healthcare Conference –
New York City , NY
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 4th. Joe Ciaffoni will also participate in a fireside discussion on Wednesday, June 4th at 9:55 a.m.
- Goldman Sachs 46th Annual Global Healthcare Conference –
Miami, FL
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 11th. Interested investors should contact their Goldman Sachs representative to schedule a meeting.
- Northland Growth Conference 2025 – Virtual
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings virtually on Wednesday, June 25th. Interested investors should contact their Northland representative to schedule a meeting.
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-upcoming-investor-events-302453910.html
SOURCE Indivior PLC